Worldwide Clinical Trials (Worldwide) is a full-service global contract research organization (CRO) that works in partnership with biotechnology and pharmaceutical companies to create customized solutions that advance new medications – from discovery to reality. Worldwide’s capabilities include bioanalytical laboratory services, Phase I-IV clinical trials, and post-approval and real-world evidence studies – all powered by an accessible team of clinicians, scientists, and researchers who bring first-hand expertise and a collaborative, personalized approach to each clinical program. Worldwide is therapeutically focused on neuroscience, oncology, rare disease, cardiometabolic, and immune-mediated inflammatory diseases. Its global footprint spans over 60 countries with more than 3,500 team members. For more information on Worldwide, visit www.worldwide.com.
External link for Worldwide Clinical Trials
#ACC25 is such a fantastic opportunity to connect with the global #Cardiology community! Make sure to say hello to our Worldwide team members at booth 19005!
Thank you to all the clients, partners, KoLs and friends who had stopped by at our booth at ACC. If you have not heard yet about Worldwide innovative approaches to cardiometabolic clinical trials, meet us at booth #19005. #WorldwideCardiometabolicTeam #ACC2025
In CAR T-cell therapy, the site can make or break your study. That's why selecting the right site is among the critical first steps to a successful #CARTClinicalTrial. Find out how to do so in Pharmaceutical Executive's roundtable video series, Episode 6, featuring our very own Steve Chriscoe. Watch on-demand today: https://ow.ly/WIzu50VpTWG
Join Dr. Tom Babic at #ADPD2025 next week to hear his presentation on the latest advancements in #Biomarker utilization for CNS-ASRD treatment trials! He will also be participating in a panel discussing innovative strategies to help support treatments for #Parkinson’sDisease (PD), Lewy body dementia (LBD), and multiple system atrophy (MSA). Don’t miss the opportunity to hear his expert insights! https://ow.ly/gRx350VpNCp
Thank you, Amy Raymond, PhD, PMP, for participating in the panel "Optimizing Gene Therapy Programs for Patient Communities of Any Size" at the Gene Therapy Development Summit! These multi-stakeholder discussions will continue to play a crucial role in advancing life-changing treatments for patients. Did you attend this year? Share your own experience at the #GeneTherapySummit25 below! https://lnkd.in/eP3PTt5R
Passionate Solutioneer, focused on bringing new treatments to rare disease patient communities
Many thanks to Anjulika Chawla, Winston Yan, MD PhD, Jennifer Casagrande, and Melissa Penn, JD, MPH for generously sharing their insights on the expert panel at #GeneTherapy24 as we discussed how we all optimize our gene therapy and gene editing trials. This is how we advance revolutionary medicines: together!
Congratulations to our incredible team members for being recognized as finalists in the 2025 PharmaTimes International Clinical Researcher of the Year award program! Anita Janowska Teodora Kisic Jelena Scepanovic Aleksandra Simic Svjetlana Novković Biserka Dinic This accomplishment is a testament to their dedication to advancing clinical research, and we’re so grateful they're part of the Worldwide team! https://ow.ly/WHuX50Vot2w
Interested in learning about the emerging trends and growth areas from the perspective of the #Oncology market? Reserve your spot at #COGNordics today to hear invaluable insights from Matt Cooper, PhD, and get the chance to speak with him at booth 2: https://ow.ly/ePFo50VnGbf
Such fascinating insights on the value of an effective pitch deck from our very own cofounder, Michael Murphy M.D., Ph.D.! Make sure to check out his article today!
As Co-founder and Chief Medical and Scientific Officer of Worldwide Clinical Trials, I’ve seen how a well-crafted pitch deck using storytelling and audience alignment can transform a technical and scientific presentation into a compelling corporate message.
At the Gene Therapy Development Summit next week, our Amy Raymond, PhD, PMP will be participating in a panel discussion that will highlight friction points in the gene therapy development lifecycle and how to overcome them, real-world examples across different patient communities, analysis of recent trends, and more. You’ll also have the opportunity to hear from the following: Anjulika Chawla, Vice President, Medical Affairs, Clinical Lead, bluebird bio Melissa Penn, JD, MPH, Director, Patient Engagement, Research & Development, Bayer Winston Yan, MD PhD, Cofounder, Head of Translational Strategy, Arbor Biotechnologies Jennifer Casagrande, Director of Clinical Operations, Arbor Biotechnologies Don’t miss the chance to reserve your spot: https://ow.ly/gB8b50VmfPG
March is #MultipleMyelomaAwareness Month, and while treatment options have expanded over the years, this month is a time to advocate for further progress. Multiple myeloma is a complex and often relentless disease, but thanks to dedicated researchers, clinical trial participants, and healthcare professionals, we continue to see advancements that bring real hope. At Worldwide, we’re proud to support #Oncology clinical research that helps bring innovative therapies to those who need them most. This month, we honor those living with multiple myeloma and reaffirm our commitment to accelerating research that makes a difference. Check out the latest advancements in multiple myeloma and other hematological cancers today: https://ow.ly/yAX150VlCLn
Have you watched the Pharmaceutical Executive roundtable video series yet? Watch Episode 1 on-demand today for key insights into the CAR T-cell #ClinicalTrial landscape from Steve Chriscoe: https://ow.ly/iTsU50Vl1sv